Literature DB >> 15341725

The crystal and solution structure of a putative transcriptional antiterminator from Mycobacterium tuberculosis.

J Preben Morth1, Vicki Feng, L Jeanne Perry, Dmitri I Svergun, Paul A Tucker.   

Abstract

We describe the crystal structure of Rv1626 from Mycobacterium tuberculosis at 1.48 A resolution and the corresponding solution structure determined from small angle X-ray scattering. The N-terminal domain shows structural homology to the receiver domains found in bacterial two-component systems. The C-terminal domain has high structural homology to a recently discovered RNA binding domain involved in transcriptional antitermination. The molecule in solution was found to be monomeric as it is in the crystal, but in solution it undergoes a conformational change that is triggered by changes in ionic strength. This is the first structure that links the phosphorylation cascade of the two-component systems with the antitermination event in the transcriptional machinery. Rv1626 belongs to a family of proteins, which we propose calling phosphorylation-dependent transcriptional antitermination regulators, so far only found in bacteria, and includes NasT, a protein from the assimilatory nitrate/nitrite reductase operon of Azetobacter vinelandii.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341725     DOI: 10.1016/j.str.2004.06.018

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  18 in total

1.  NasT-mediated antitermination plays an essential role in the regulation of the assimilatory nitrate reductase operon in Azotobacter vinelandii.

Authors:  Baomin Wang; Leland S Pierson; Christopher Rensing; Malkanthi K Gunatilaka; Christina Kennedy
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

Review 2.  Adaptation to environmental stimuli within the host: two-component signal transduction systems of Mycobacterium tuberculosis.

Authors:  Daniel J Bretl; Chrystalla Demetriadou; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

Review 3.  Ethanolamine utilization in bacterial pathogens: roles and regulation.

Authors:  Danielle A Garsin
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

4.  Manual classification strategies in the ECOD database.

Authors:  Hua Cheng; Yuxing Liao; R Dustin Schaeffer; Nick V Grishin
Journal:  Proteins       Date:  2015-05-08

5.  1.9 A structure of the signal receiver domain of the putative response regulator NarL from Mycobacterium tuberculosis.

Authors:  Robert Schnell; Daniel Agren; Gunter Schneider
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-11-28

6.  Principal Component Analysis of Proteome Dynamics in Iron-starved Mycobacterium Tuberculosis.

Authors:  Prahlad K Rao; Qingbo Li
Journal:  J Proteomics Bioinform       Date:  2009-01-15

7.  Found: the elusive ANTAR transcription antiterminator.

Authors:  Valley Stewart; Herman van Tilbeurgh
Journal:  PLoS Genet       Date:  2012-06-07       Impact factor: 5.917

8.  The mechanism for RNA recognition by ANTAR regulators of gene expression.

Authors:  Arati Ramesh; Sruti DebRoy; Jonathan R Goodson; Kristina A Fox; Herbey Faz; Danielle A Garsin; Wade C Winkler
Journal:  PLoS Genet       Date:  2012-06-07       Impact factor: 5.917

9.  Understanding communication signals during mycobacterial latency through predicted genome-wide protein interactions and boolean modeling.

Authors:  Shubhada R Hegde; Hannah Rajasingh; Chandrani Das; Sharmila S Mande; Shekhar C Mande
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

10.  Extensive DNA mimicry by the ArdA anti-restriction protein and its role in the spread of antibiotic resistance.

Authors:  Stephen A McMahon; Gareth A Roberts; Kenneth A Johnson; Laurie P Cooper; Huanting Liu; John H White; Lester G Carter; Bansi Sanghvi; Muse Oke; Malcolm D Walkinshaw; Garry W Blakely; James H Naismith; David T F Dryden
Journal:  Nucleic Acids Res       Date:  2009-06-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.